Autopsy report · NCT03640988

The Effects of High Energy Acoustic Shock Wave Therapy on Local Skin Perfusion and DFUs

“Mfr of product identified in protocol to measure perfusion after treatment with sponsor device withdrew support from the study. Sponsor decided to cancel the investigation due to lack of adequate replacement.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 8 months before it started.
• Ran for about 1 year 8 months before it stopped.
• 2 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

SANUWAVE, Inc.

Sponsor type

Industry

Conditions

Diabetic Foot Ulcer

Interventions

dermaPACE

Participants

2

Sites

1

Countries

United States

Trials that died the same way

• A Study of Full Treatment-free Remission in Patients With Chronic Myeloid Leukemia
  “Sponsor decision: The primary endpoint of the core/TF1 was achieved, and the sample size of Extension/TFR2 was unlikely to yield meaningful results. No new safety signals were observed. For these reasons, continuing the study was not justified.” (56% match in meaning)
• AcQMap® US Registry of Procedural and Long-term Clinical Outcomes (Discover-US)
  “Sponsor no longer performing clinical studies. Will only be a manufacturer” (56% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.